New research explains why stem cells become resistant to cancer treatment and opens a clever new way to go after them.
Nicole Fawcett is the manager of cancer communication for the University of Michigan Rogel Cancer Center, overseeing media relations, marketing, web, internal communication, social media and publications for the center’s research and clinical enterprises. She leads a team of four communicators who produce targeted, innovative communication to meet the Cancer Center’s goals. Nicole joined Michigan Medicine in 2003. Prior to that, she was at the Detroit News and at a startup web-based community for people with disabilities.
Tumors with alterations in the CDK12 gene were more responsive to immunotherapy, suggesting a precision medicine approach.
Researchers identify a lncRNA that provides insight into a key driver of prostate cancer — and a potential target for future therapy.
Researchers have discovered the process that allows immune suppressor cells to develop, suggesting a potential new way to bolster immunotherapy treatment.
A surprising finding explains how a crucial cancer gene impacts cell signaling to drive cancer growth.
A newly announced $150 million gift to the University of Michigan Rogel Cancer Center will help fill the gaps in federal funding and support high-risk, high-reward